A. Pichugin, S.A. Podsvirova, E. Ushakova, D.M. Spirin, E. Lebedeva, R. Ataullakhanov
{"title":"肿瘤微环境髓系细胞重编程提高CTLA-4和PD-1阻断在实验性恶性黑色素瘤免疫治疗中的效率","authors":"A. Pichugin, S.A. Podsvirova, E. Ushakova, D.M. Spirin, E. Lebedeva, R. Ataullakhanov","doi":"10.33029/0206-4952-2022-43-6-673-690","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":38750,"journal":{"name":"Immunologiya","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reprogramming of myeloid cells of the tumor microenvironment increases the efficiency of CTLA-4 and PD-1 blockade in experimental malignant melanoma immunotherapy\",\"authors\":\"A. Pichugin, S.A. Podsvirova, E. Ushakova, D.M. Spirin, E. Lebedeva, R. Ataullakhanov\",\"doi\":\"10.33029/0206-4952-2022-43-6-673-690\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":38750,\"journal\":{\"name\":\"Immunologiya\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immunologiya\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33029/0206-4952-2022-43-6-673-690\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Immunology and Microbiology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunologiya","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33029/0206-4952-2022-43-6-673-690","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
Reprogramming of myeloid cells of the tumor microenvironment increases the efficiency of CTLA-4 and PD-1 blockade in experimental malignant melanoma immunotherapy